Ribomic Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	0.75	2	-	65	80	91
Revenue Growth (YoY)	-64.40%	-	-	-18.75%	-12.09%	-24.79%
Gross Profit	0.75	2	-	65	80	91
Selling, General & Admin	398.96	385	352	361	313	304
Research & Development	664.67	667	764	1,491	1,482	957
Other Operating Expenses	-	-	-	-	34	69
Operating Expenses	1,064	1,052	1,116	1,852	1,829	1,331
Operating Income	-1,063	-1,050	-1,116	-1,787	-1,749	-1,240
Interest & Investment Income	8.37	4	1	2	-	-
Currency Exchange Gain (Loss)	-1.31	-	10	20	11	-9
Other Non Operating Income (Expenses)	17.93	31	122	116	103	63
EBT Excluding Unusual Items	-1,038	-1,015	-983	-1,649	-1,635	-1,186
Asset Writedown	-2.87	-2	-40	-3	-48	-
Pretax Income	-1,041	-1,017	-1,023	-1,652	-1,683	-1,186
Income Tax Expense	1.41	1	1	1	1	1
Net Income	-1,042	-1,018	-1,024	-1,653	-1,684	-1,187
Net Income to Common	-1,042	-1,018	-1,024	-1,653	-1,684	-1,187
Shares Outstanding (Basic)	47	40	36	31	28	26
Shares Outstanding (Diluted)	47	40	36	31	28	26
Shares Change (YoY)	22.92%	13.25%	14.73%	10.70%	9.29%	61.26%
EPS (Basic)	-22.12	-25.19	-28.69	-53.14	-59.92	-46.16
EPS (Diluted)	-22.12	-25.19	-28.69	-53.14	-59.92	-46.16
Free Cash Flow	-	-1,028	-954	-1,731	-1,509	-1,150
Free Cash Flow Per Share	-	-25.43	-26.73	-55.64	-53.70	-44.73
Gross Margin	100.00%	100.00%	-	100.00%	100.00%	100.00%
Operating Margin	-141716.67%	-52500.00%	-	-2749.23%	-2186.25%	-1362.64%
Profit Margin	-138954.00%	-50900.00%	-	-2543.08%	-2105.00%	-1304.40%
Free Cash Flow Margin	-	-51400.00%	-	-2663.08%	-1886.25%	-1263.74%
EBITDA	-1,067	-1,049	-1,106	-1,787	-1,734	-1,214
D&A For EBITDA	-4.17	0.92	10	0.48	15	26
EBIT	-1,063	-1,050	-1,116	-1,787	-1,749	-1,240

Source: S&P Global Market Intelligence. Standard template. Financial Sources.